↓ Skip to main content
What is this page? Embed badge

Advances in Targeted Cancer Therapy

Overview of attention for book
Cover of 'Advances in Targeted Cancer Therapy'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Dawn of a new era in molecular cancer therapeutics
  3. Altmetric Badge
    Chapter 2 Obtacles and opportunities in the clinical development of targeted therapeutics
  4. Altmetric Badge
    Chapter 3 Tumor models for preclinical development of targeted agents
  5. Altmetric Badge
    Chapter 4 Angiogenesis inhibitors: What is the clinical future?
  6. Altmetric Badge
    Chapter 5 Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy
  7. Altmetric Badge
    Chapter 6 Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development.
  8. Altmetric Badge
    Chapter 7 Targeted histone deacetylase inhibition for cancer prevention and therapy.
  9. Altmetric Badge
    Chapter 8 Inhibitors of cyclin-dependent kinase modulators for cancer therapy
  10. Altmetric Badge
    Chapter 9 Targeting cyclooxygenase-2 for cancer prevention and treatment
  11. Altmetric Badge
    Chapter 10 Antisense approaches in drug discovery and development
  12. Altmetric Badge
    Chapter 11 Preclinical development of Alimta™ (Pemetrexed, LY231514), a multitargeted antifolate
Attention for Chapter 10: Antisense approaches in drug discovery and development
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
Summary Dimensions citations
So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.